Completed PHASE2 INTERVENTIONAL 3-arm NCT02457260

Oral Nitrite for Older Heart Failure Patients (ONTx+HF)

Study of the Utility of Oral Nitrite Therapy to Improve Skeletal Muscle Bioenergetics and Physical Capacity in Older Heart Failure Patients

Sponsor: Gladwin, Mark, MD

Conditions Heart Failure

Interventions 14 N Sodium Nitrite

Updated 12 times since 2017 Last updated: Aug 20, 2018 Started: Jan 8, 2016 Primary completion: Mar 6, 2017 Completion: Mar 6, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02457260, this PHASE2 trial focuses on Heart Failure and remains completed. Sponsored by Gladwin, Mark, MD, it has been updated 12 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 7 earlier versions

Oct 2018 — Jan 2021 [monthly]

Completed PHASE2
Aug 2018 — Oct 2018 [monthly]

Completed PHASE2
Jun 2018 — Aug 2018 [monthly]

Completed PHASE2
Feb 2018 — Jun 2018 [monthly]

Completed PHASE2
May 2017 — Feb 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — May 2017 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gladwin, Mark, MD

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States